Dermira (DERM) Tops Q3 EPS by $1.15

Go back to Dermira (DERM) Tops Q3 EPS by $1.15

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

November 7, 2023 4:01 PM EST

Company generated total net revenues of $34.5 million in the third quarter of 2023, a 101% increase from $17.2 million in the second quarter of 2023

GAAP net income increased to $16.8 million, or $0.91 per share basic and $0.80 per share diluted, for the third quarter of 2023, compared to a GAAP net loss of $10.1 million, or $0.57 per share basic and diluted for the third quarter of 2022

Received an... More